Rapid advances in oncology are creating innovative treatment options producing very successful outcomes for some patients. These novel cancer therapies are also creating significant payment challenges for health care purchasers and health insurance subscribers. These challenges have sparked interest in new payment arrangements to maximize the value of spending on these drugs.
Join us for a special NEHI webinar at 10 am ET on Thursday, October 26, that will explore prospects for value-based purchasing in oncology. NEHI President and CEO Susan Dentzer will moderate a discussion with Claire Brunken, Executive Director of Outcomes Projects for Novartis, and Dr. Michael Sherman, Chief Medical Officer and Senior Vice President of Harvard Pilgrim Healthcare.
The webinar will follow the October 24 release of a new NEHI white paper, “Value-Based Contracting for Oncology Drugs.”